CREATE MEDIC CO.,LTD., January-September (Third Quarter Cumulative) Ordinary Profit Decreases by 16%, July-September Ordinary Profit Decreases by 29%

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Thu Oct 31, 2024 3:00 pm JST Earnings

5187 CREATE MEDIC CO.,LTD. 【J-GAAP】

Earnings Report

CREATE MEDIC CO.,LTD. <5187> [TSE-S] announced its financial results after the market closed on October 31st (15:00). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending December 2024 (January to September) decreased by 16.3% from the same period last year to 545 million yen. The progress rate against the 900 million yen full-year plan was 60.6%, also falling below the five-year average of 74.4%.

Based on the third-quarter cumulative performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the October to December period (4Q) is expected to expand by 60.6% from the same period last year, reaching 355 million yen.

In the most recent three-month period, from July to September (3Q), the consolidated ordinary profit decreased to 200 million yen, a 28.6% decrease compared to the same period last year. The operating profit margin worsened from 8.8% in the same period last year to 7.2%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Jan - Sep, 2022	9,047	621	755	483	53.2	90.5	Oct 31, 2022	J-GAAP
Jan - Sep, 2023	9,168	612	651	9	1.1	74.7	Oct 31, 2023	J-GAAP
Jan - Sep, 2024	9,512	521	545	744	83.9	60.6	Oct 31, 2024	J-GAAP
YoY	+3.8%	-14.9%	-16.3%	+8,166.7%	+7,810.4%

Current Period Guidance

Second Half Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jul - Dec, 2023	6,560	468	501	-162	-17.8	20	Feb 14, 2024	J-GAAP
Jul - Dec, 2024 Guidance	6,732	577	555	417	48.6	20	Aug 5, 2024	J-GAAP
YoY	+2.6%	+23.3%	+10.8%	－	－

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Dec, 2022	12,326	741	834	482	53.0	37	Feb 13, 2023	J-GAAP
Dec, 2023	12,585	803	872	154	16.9	37	Feb 14, 2024	J-GAAP
Dec, 2024 Guidance	13,032	868	900	967	112.6	39	Feb 14, 2024	J-GAAP
YoY	+3.6%	+8.1%	+3.2%	+527.9%	+565.4%

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Jul - Sep, 2023	3,143	277	280	-307	-36.2	8.8	Oct 31, 2023	J-GAAP
Oct - Dec, 2023	3,417	191	221	145	15.9	5.6	Feb 14, 2024	J-GAAP
Jan - Mar, 2024	2,976	98	106	59	6.5	3.3	May 7, 2024	J-GAAP
Apr - Jun, 2024	3,324	193	239	491	54.8	5.8	Aug 5, 2024	J-GAAP
Jul - Sep, 2024	3,212	230	200	194	21.9	7.2	Oct 31, 2024	J-GAAP
YoY	+2.2%	-17.0%	-28.6%	－	－